Source: LEPIDEXT L.L.C submitted to NRP
A BIOLOGICAL ALTERNATIVE TO CHEMICAL PESTICIDES TO CONTROL CORN EARWORM IN HAWAII
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1030096
Grant No.
2023-51402-39330
Cumulative Award Amt.
$175,000.00
Proposal No.
2023-01160
Multistate No.
(N/A)
Project Start Date
Jul 1, 2023
Project End Date
Jun 30, 2025
Grant Year
2023
Program Code
[8.2]- Plant Production and Protection-Biology
Recipient Organization
LEPIDEXT L.L.C
1122 OAK HILL DR
LEXINGTON,KY 40505
Performing Department
(N/A)
Non Technical Summary
The seed corn industry in Hawaii is the largest agricultural industry in the state. At $151M (2016 figures), it represents 25% of the State's sector GDP. The islands' tropical climate allows for year-round corn breeding and propagation practices. The constant presence of corn in Hawaii supports more than a dozen flights of corn earworm (CEW) per year making Helicoverpa zea a more significant problem (The Problem) relative to cooler climates. Lepidext is developing novel, naturally occurring biopesticides to decrease insect populations. Lepidext's first biopesticide (The Solution), InsterusHzTM, is a sexually transmitted virus that sterilizes adult moths, suppressing CEW infestations and reducing subsequent generations. The purpose of this Phase I STTR project is to prove the feasibility of InsterusHz as a powerful tool to reduce H. zea infestations to below kernel damage thresholds in seed corn production systems.
Animal Health Component
25%
Research Effort Categories
Basic
(N/A)
Applied
25%
Developmental
75%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
2154030113050%
2151510106050%
Goals / Objectives
Two objectives proposed for Phase I are: to develop low input methods for continuous and synchronous production and delivery of InsterusHz moths for use in Hawaii (Objective 1); and, to evaluate the use of InsterusHz to reduce H. zea infestations in seed corn field plots and refine application models for its delivery (Objective 2). A successful Phase 2 project would develop the approaches and help to define the complementary technologies required to suppress corn earworm (CEW) population levels, lowering the need for chemical controls in Phase 3.
Project Methods
Lepidext proposes to develop technology/s to upscale the production of InsterusHz moths and transfer the skills to the University of Hawaii to evaluate Lepidext's technology in their cornfield plots.Lepidext will scale up insect production by designing methods for egg collection and distribution, increasing egg "shelf-life" for synchronization, a grid system diet delivery and individual housing, and final housing for storage and shipment.Further, with the help of a statistical model, we will optimize the number of Insterus moths to be continuously released into the fields for pest suppression below critical damage.Finally, the University of Hawaii and Hawai'i Foundation collaborators will evaluate the developed models of application and population suppression on dedicated field plots (control and experimental) where InsterusHz moths would be released weekly at the silk stage.

Progress 07/01/23 to 06/30/24

Outputs
Target Audience:This project has several target audiences. First, the seed corn industry that requires plantings that contain both Bt-expressing and non-Bt-expressing strains, leaving no guarantee of protection for non-Bt crops. Second, farmers of Bt-expressing crops, notably corn and cotton, are a major target for this product. These farmers are experiencing the resistance development in the corn earworm and the high cost of newer Bt traits. Third, sweet corn farmers relying on chemical pesticides. Our product provides the industry with opportunities to reduce chemical pesticide resistance development in the corn earworm. Several farmers are also investors in Lepidext. Lepidext has also been in communication with the agrichemical companies that have developed Bt traits. There are varied responses to our new technology which Lepidext believes can extend the utility of Bt traits and reduce chemical pesticide application. Lepidext is also in regular communication with both actual and prospective investors regarding this technology individually and through investor forums. Changes/Problems:The most time-consuming challenges were to request all permits from various agencies at different levels (federal, state, and UH) in order to actually initiate this research legally in Hawaii. Although we started permit applications as soon as the project started in July 2023, the last permit needed was approved on 03/27/2024. The main technical challenge was building a H. zea colony at the University of Hawaii (UH) due to strict permit requirements to ship lab reared pupae from the continental U.S. to Hawaii. We decided to collect eggs from the field and rear them to start a colony for our trials to begin releases sooner than if we attempted to acquire a permit. Due to starting a colony from the field we have been facing high mortality in early generations while the colony stabilizes. We also had to switch the company providing the seed corn plots which took additional time to organize. In summary, no major changes, but the project has been delayed due to reasons mentioned above. Therefore, a one-year no cost extension was requested to fulfill all project goals. What opportunities for training and professional development has the project provided?The Cheng laboratory has fulfilled the requisite training mandated by the University of Hawai'i Biosafety Office. How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?Dr. Cheng's laboratory will continue to establish and maintain the H. zea colony. Field trials will start early July 2024 and will provide data on the efficacy of the InsterusHz biopesticide in the field. Lepidext will continue to optimize and scale-up InsterusHz production and will use the data obtained in the field trials to model year-round H. zea populations and continuous release of InsterusHz moths.

Impacts
What was accomplished under these goals? Lepidext is developing novel, naturally occurring biopesticides to decrease insect populations. Lepidext's first biopesticide (The Solution), InsterusHzTM, is a sexually transmitted virus that sterilizes adult moths, suppressing corn earworm (CEW) infestations and reducing subsequent generations. InsterusHzTM is a patented strain of the sterilizing entomopathogen HzNV2 (Helicoverpa zea nudivirus 2) with markedly increased sterilizing efficiency relative to the wild-type virus. Progress has been made to develop low input methods for continues and synchronous production and delivery of InsterusHz moths for use in Hawaii. During this reporting period, methods to streamline H. zea egg collection and distribution are being optimized and rearing methods for high-density larval development have been established. Lepidext has transferred these rearing techniques to their collaborating laboratory at the University of Hawaii. To assess the presence of the HzNV-2 wild-type virus in Hawai'i, pheromone traps were deployed within corn fields. Subsequent retrieval of these traps resulted in the detection of wild-type virus through PCR analysis of trapped corn earworm moths. Since the beginning of the project, Dr. Cheng's team has started a lab colony from field collected eggs of H. zea which is currently in its third generation.

Publications